ARX Raw Material Antibodies & HAMA Blockers by ARX SCIENCES

ARX Sciences specializes in partnering with companies world-wide to support and develop technologies for in Vitro Diagnostic applications. They support large and small companies by providing Antibodies & Proteins optimized for assay development and research. To support their customers assay development needs, ARX has summarized their listing of matched pair antibodies with associated antigens.
Their current offerings include antibodies in the areas of Cancer Markers, Cardiac Markers, Hormones, Infectious Diseases, Inflammation, and Veterinary. The products listed are only a partial listing of their antibody/antigen catalog that continues to grow. ARX has accumulated these high-quality products through close relationships with labs fostered over decades of experience.
Their manufacturing facility in Buffalo, NY has more than doubled in size since their founding in 2019 and houses a Biosafety Level 2 lab. ARX received FDA 510K approval for Bacterial & Viral Transport media collection devices in 2023 and has continued to grow our bulk media production capacity. ARX will continue to diversify into other areas such as protein chemistry, point of care diagnostics and continue to build on their Antibody & Media offerings.
ARX values your business. It is the development of long term relationships that they are passionate about. If you are interested in their products, please contact us today!

Examples of ARX's Antibodies, Antigens & HAMA Blockers

  • ⚫︎Cancer Markers:AFP, CA15-3, CA19-19, CA125, CEA, HE4, PSA
  • ⚫︎Cardiac Markers:Hemoglobin, NT-pro, BNP, Tropinin I
  • ⚫︎Hormones:FSH, hCG, HGH, Prolactin
  • ⚫︎Infectious Diseases:Adenovirus, Dengue, Hepatitis, HIV, Influenza, RSV, Chlamydia, E. coli, Salmonella, Streptococcus
  • ⚫︎Inflammation:IL-6, IL-8, lL-10
  • ⚫︎Veterinary:Canine Coronavirus, Distemper, Parvovirus, FeLV
  • ⚫︎Purified Human Proteins and Enzymes
  • ⚫︎HAMA Blockers
  • Their offerings include pre-qualified matched antibodies to assist with assay development.